Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
OR11-01 efficacy and safety of setmelanotide in acquired hypothalamic obesity: results from a double-blind, multicenter, placebo-controlled, randomized phase 3 trial
Our goal is to replace hype with trusted health information so patients can work with their doctors to choose safe, evidence-based therapies. The campaign launched during Obesity Care Week, a global awareness initiative focused on improving access to evidence-based obesity treatment and combating stigma around the disease
Twenty-four studies included individuals with T2D
Neuropeptide Y (NPY), another highly conserved neuropeptide, contributes to controlling energy homeostasis, anxiety and sleep
According to the company, the clinical data package supporting retatrutide is complete, and it is finalizing the Chemistry, Manufacturing, and Controls (CMC) package required for regulatory submission
